London biometric authentication firm iProov announces “record-breaking” growth

A London-headquartered biometric authentication business saw a 15x increase in the number of people verified using its technology in the first six months of 2021 versus the same time period last year.

iProov offers online facial biometric authentication, working with governments, financial institutions and other enterprises to securely verify customer identity.

Founded in 2012, iProov ’s patented technology assures the genuine presence of an online user to ensure they are the correct person.

The growth has been driven by demand from organizations needing to verify the identity of online users to prevent fraud.

Andrew Bud, founder and CEO, iProov commented: “The dramatic acceleration in the digital identity market, caused by the pandemic, has demonstrated our market leadership based on our unrivalled usability, inclusiveness and resilient security, and the extraordinary scalability of our platform.”

The business has established a global footprint with offices in the UK, US and Singapore growing its worldwide team by 25% to 85.

iProov customers include the U.S. Department of Homeland Security, the UK Home Office, and the UK National Health Service (NHS).

Since 2020, iProov has enabled users in England to create an NHS login remotely and securely.

A user scans their identity document, such as a valid passport or driver’s license, and then completes a brief iProov face verification to confirm their identity, giving them secure access to the services of the NHS App.

Since May 2021, this has included the COVID vaccination status service.